True about montelukast is:
First, I need to recall what montelukast does. Montelukast is a leukotriene receptor antagonist. It's used in asthma and allergic rhinitis. It works by blocking the cysteinyl leukotriene receptors, specifically CysLT1. This prevents the action of leukotrienes, which are inflammatory mediators involved in bronchoconstriction and increased mucus production.
Now, the possible options might include things like its mechanism, uses, side effects, or contraindications. Let's think of common distractors. For example, a wrong option might say it's a beta-agonist, which it's not. Another might say it's used for acute asthma attacks, but montelukast is a controller medication, not for acute relief. Another wrong option could mention it being a corticosteroid, which it isn't. Also, maybe an option about it being a mast cell stabilizer, which would be incorrect.
The correct option should state that montelukast is a leukotriene receptor antagonist. So, in the explanation, the core concept is its role as a CysLT1 antagonist. The correct answer explanation would detail how it blocks leukotrienes' actions. The wrong options would be about different mechanisms or uses.
Clinical pearls here might include that montelukast is not for acute asthma but long-term control, and that it's often used in combination with inhaled corticosteroids. Also, it's available as a chewable tablet for children, which is a high-yield fact for exams.
I need to structure the explanation with the specified sections. Make sure each part is concise, uses correct terminology, and addresses each required section without exceeding the character limit. Let me check each part for accuracy and clarity.
**Core Concept**
Montelukast is a **leukotriene receptor antagonist** that selectively blocks **cysteinyl leukotriene receptor 1 (CysLT1)**. It is used in asthma and allergic rhinitis to inhibit the inflammatory actions of leukotrienes, such as bronchoconstriction and mucus secretion.
**Why the Correct Answer is Right**
Montelukast works by **inhibiting CysLT1**, preventing leukotrienes like LTC4, LTD4, and LTE4 from binding. This reduces airway inflammation, bronchoconstriction, and vascular permeability. It is a **long-term controller** for asthma, not an acute rescue medication, and is also used in exercise-induced bronchoconstriction and allergic rhinitis.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect if it claims montelukast is a beta-2 agonist—this describes drugs like albuterol, which act on adrenergic receptors.
**Option B:** Incorrect if it states montelukast is a corticosteroid—its anti-inflammatory action is distinct from glucocorticoids.
**Option C:**